CD44 and glioma: Even though absence of CD44 strongly disrupted glioma invasion in brain slices and in vitro, cell invasion from DKO11804 and GL261-derived tumors was only mildly affected in myeloid CD44-deficient syngeneic hosts, despite the significant differences of both cell lines in respect to tumor growth and infiltration of the surrounding tissue.